Injection formulation of astragalus root saponin and its preparation mehod

A glycoside injection, technology of total astragalus glycosides, applied in the field of medicine, can solve the problems of poor water solubility of total astragalus glycosides, many impurities, difficult to obtain stable and satisfactory preparations and the like

Inactive Publication Date: 2004-03-17
SHANGHAI JINGFENG PHARMA +1
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The content of total astragalosides in Astragalus injection currently used clinically is not high, and the difference is large, and the drug effect is not easy to control; at the same time, because the content is not high and there are many impurities, patients have many adverse reactions after taking medicine, esp

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1 (small injection);

[0044] Component Quantity (g / bottle)

[0045] Astragalus total extract (calculated as total astragalosides) 0.02

[0046] Ethanol 0.50

[0047] Propylene glycol 0.40

[0048] Glycerin 0.10

[0049] Mannitol 0.03 preparation process is:

[0050] Take total astragalosides, add mannitol, add ethanol, glycerin and propylene glycol to dissolve, filter and sterilize, subpackage and seal, and sterilize to obtain.

Embodiment 2

[0051] Embodiment 2 (powder injection);

[0052] Component Quantity (g / bottle)

[0053] Astragalosides 0.01

[0054] Mannitol 0.03 preparation process is:

[0055] Take total astragalosides, add mannitol, add 20ml of water, heat to dissolve, weigh hot filter to sterilize, sub-package, and freeze-dry to obtain.

Embodiment 3

[0056] Embodiment 3 (powder injection)

[0057] Component Quantity (g / bottle)

[0058] Astragalosides 0.03

[0059] The preparation process of lactose 0.05 is:

[0060] Take total astragalosides, lactose, add 10ml of ethanol, dissolve, filter and sterilize, spray dry, aseptically sub-package, and press the cap to get it.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention is general astragaloside injection and its preparation process. The present invention screens some co-solvent and co-solving diluent including propylene glycol, ethanol, glycerine, polyglycol, benzyl benzoate, dimethyl acetamide, etc. to increase the dissolubility of general astragaloside in water. Each injection contains general astragaloside 5-50 mg, and medicinal supplementary material including diluent, co-solvent, excipient, osmotic pressure regulator, etc. The present invention has determined curative effect.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to a pharmaceutical preparation of total astragalosides, more specifically to a kind of injection of total astragalosides (including small injections, powder injections, glucose infusion and sodium chloride infusion). It relates to a preparation method of the preparation. Background technique [0002] Astragalus is a traditional traditional Chinese medicine that invigorates qi and strengthens the surface, diuretics and toxins, drains pus, and suppresses sores and promotes granulation. A large number of studies have shown that the active ingredient of Astragalus is total glycosides of Astragalus. Traditional Chinese medicine believes that qi stagnation and blood stasis are one of the main causes of cardiovascular and cerebrovascular diseases. Astragalosides are used to treat qi stagnation and blood stasis cardiovascular and cerebrovascular diseases, and the curative effe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/14A61K9/19A61K31/7048A61P9/10
Inventor 张川张卫东李慧梁苏娟
Owner SHANGHAI JINGFENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products